In the present study, we investigated the antitumour activity and expression of biological factors in a selected population of premenopausal patients with locally advanced breast cancer whose tumours expressed both ER and progesterone receptor (PgR) in at least 10% of tumour cells. Here, PGR is linked to neoplasm.